ABBY ORLANSKY: Open Payments
NPI 1265125538 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 83 payments from 15 companies in 2025. Trend: 2023 $19 · 2024 $2,150 · 2025 $1,704
Food & beverage: $1,630Education: $75
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $337 |
| ABBVIE INC. | 15 | $317 |
| Janssen Biotech, Inc. | 14 | $236 |
| GENZYME CORPORATION | 8 | $173 |
| UCB, Inc. | 9 | $162 |
| Organon LLC | 5 | $70 |
| Lilly USA, LLC | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $63 |
| Incyte Corporation | 3 | $61 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $56 |
Products named: CIBINQO, TREMFYA, DUPIXENT, Bimzelx, RINVOQ, BOTOX, SKYRIZI, TALTZ.
Industry payments across MD — which companies pay providers there.
